REFERENCES
- Morita A, Ebersold M J, Olsen K D, et al. Esthesioneuroblastoma Prognosis and management. Neurosurgery 1993; 32: 706–715
- Ghaffar S, Salahuddin I. Olfactory neuroblastoma: A case report and review of the literature. Ear Nose Throat J 2005; 84: 150–152
- Kadish S, Goodman M, Wang C C. Olfactory neuroblastoma. A clinical analysis of 17 cases. Cancer 1976; 23: 1571–1676
- Broich I, Pagliari A, Ottaviani F. Esthesioneuroblastoma: a general review of cases published since the discovery of the tumour in 1924. Anticancer Res 1997; 17: 2683–2706
- Jethanamest Daniel, Luc G., Morris Andrew G., Sikora David I. Kutler. Esthesioneuroblastoma. A population-based analysis of survival and prognostic factors. Arch Otolaryngol Head Neck Surg 2007; 133: 276–280
- Berman E L, Chu A, Wirtschafter J D, et al. Esthesioneuroblastoma presenting as sudden unilateral blindness. Histopathologic confirmation of optic nerve demyelination. J Clin Neuroophthalmol 1992; 12: 31–36
- Lee A G, Tang R A. Third nerve palsy as the presenting manifestation of esthesioneuroblastoma. J Neuroophthalmol 2000; 20: 20–1
- Eriksen J G, Bastholt L, Krogdahl A S, et al. Esthesioneuroblastoma—what is the optimal treatment?. Acta Oncol 2000; 39: 231–235
- Bailey B J, Barton S. Olfactory neuroblastoma—management and prognosis. Arch Otolaryngol 1975; 101: 1–5
- Bhattacharyya N, Thornton A F, Joseph M P, Goodman M L, Amrein P C. Successful treatment of esthesioneuroblastoma and neuroendocrine carcinoma with combination chemotherapy and proton radiation: results in 9 cases. Arch Otolaryngol Head Neck Surg 1997; 123: 34–40